BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
FRST
Primis Financial Corp.
FRST has the edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FRST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FRST's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRST.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FRST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.6x | $14.64 | — |
| Cheap | 8.9x | $19.82 | +35% |
| Forward | 9.1x | $14.64 | — |
| Fair | 13x | $28.04 | +92% |
| Expensive | 53x | $117 | +697% |
Historical ranges are pointers, not guarantees.
FRST has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FRST on the outlook, with more favorable valuation expectations.
FRST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for FRST, with profitability improving. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FRST on earnings, with more consistent year-over-year improvement.
FRST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | -28% |
| Q3 2026 | $2.22 | +534% |
| Q2 2026 | $2.15 | +1692% |
| Q1 2026 | $1.87 | +1069% |
| Q4 2025 | $2.49 | +$3.15 |
| Q3 2025 | $0.35 | +$0.46 |
| Q2 2025 | $0.12 | +$0.52 |
| Q1 2025 | $0.16 | +$0.78 |
| Q4 2024 | -$0.66 | -$0.28 |
FRST earned $2.22 per share over the past year, about six times what it earned the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FRST on profitability, with a higher operating margin.
FRST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.2M | +20% |
| Q2 2026 | $55.8M | +29% |
| Q1 2026 | $45.6M | -22% |
| Q4 2025 | $80.9M | +109% |
| Q3 2025 | $41M | +9.9% |
| Q2 2025 | $43.2M | +21% |
| Q1 2025 | $58.7M | +65% |
| Q4 2024 | $38.8M | +20% |
FRST's revenue is growing: $49M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +0.9 points |
| Q2 2026 | 22% | +15 points |
| Q1 2026 | 23% | -19 points |
| Q4 2025 | 45% | +128 points |
| Q3 2025 | 21% | +24 points |
| Q2 2025 | 6.9% | -1 points |
| Q1 2025 | 42% | +38 points |
| Q4 2024 | -83% | -31 points |
FRST's operating margin was 22% last quarter, up 0.9 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with FRST at down 42%.
FRST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.8M | +$90.2M |
| Q2 2026 | -$6M | +$35M |
| Q1 2026 | -$54.6M | -259% |
| Q3 2025 | -$11.4M | -355% |
| Q2 2025 | -$41M | -181% |
| Q1 2025 | $34.4M | +$35.4M |
| Q4 2024 | -$35.7M | -152% |
| Q3 2024 | $4.5M | +$5.4M |
FRST's free cash flow was $7M over the past year, against −$38M the year before. Free cash flow isn't a meaningful measure for financial services companies like FRST.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FRST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FRST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | +0.6% | +155K shares |
| 3 years | +0.6% | +157K shares |
| 5 years | +0.7% | +165K shares |
| Available history | +1.9% | +474K shares |
FRST has 25M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FRST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -17.4x | Net Cash |
| Q1 2025 | -9.4x | Net Cash |
| Q3 2023 | -7.1x | Net Cash |
FRST has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FRST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 6.2 | Oversold |
FRST's weekly RSI is 44 (neutral) and its Stochastic is 6 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FRST PE vs Financial Services Sector
| Metric | FRST | Sector median | Relative |
|---|---|---|---|
| PE | 6.6x | 13x | 49% below |
| PE % | 3 | 63 | 60 pts below |
FRST has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FRST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 3.4% below |
| 20 week MA | $15.7 | 6.7% below |
| 50 week MA | $14.6 | 0.3% above |
| 100 week MA | $12.5 | 17% above |
| 200 week MA | $11.6 | 27% above |
FRST has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FRST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.4 | $12.1 | -26% |
| 2021 | $12.1 | $15.0 | +24% |
| 2022 | $15.0 | $11.8 | -21% |
| 2023 | $11.8 | $12.7 | +7.7% |
| 2024 | $12.7 | $11.7 | -7.9% |
| 2025 | $11.7 | $13.0 | +12% |
| 2026 YTD | $13.0 | $14.6 | +12% |
FRST has the edge over BAC on returns for 2026, with the stronger performance.